Skip to main content
PMC home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1972 Aug 1;136(2):277–290. doi: 10.1084/jem.136.2.277

MECHANISM OF RECOVERY FROM SYSTEMIC VACCINIA VIRUS INFECTION

I. THE EFFECTS OF CYCLOPHOSPHAMIDE

M Worthington 1, A S Rabson 1, S Baron 1
PMCID: PMC2139199  PMID: 5043413

Abstract

Administration of Cytoxan in doses capable of inhibiting both humoral and cellular immunity markedly potentiated primary systemic vaccinia virus infection in mice. Immunosuppressed mice did not form neutralizing antibody to vaccinia virus and had a prolonged and more severe viremia than nonimmunosuppressed control mice. Passive transfer of physiologic amounts of neutralizing antibody late in the course of infection, at a time when nonimmunosuppressed mice had similar levels of serum antibody, largely reversed the effect of Cytoxan on vaccinia virus infection. Transfer of 100 million immune spleen cells was much less effective than antibody in reversing the effect of Cytoxan on vaccinia virus infection, and mice receiving these cells did make some antibody. Serum interferon levels were not affected by Cytoxan. The results suggest an essential role for humoral antibody, but not for cellular immunity, in recovery from primary vaccinia virus infection in the mouse.

Full Text

The Full Text of this article is available as a PDF (743.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BOULTER E. A., WESTWOOD J. C., MABER H. B. Value of serotherapy in a virus disease (rabbit pox). Lancet. 1961 Nov 4;2(7210):1012–1015. doi: 10.1016/s0140-6736(61)90969-2. [DOI] [PubMed] [Google Scholar]
  2. Berry D. M., Almeida J. D. The morphological and biological effects of various antisera on avian infectious bronchitis virus. J Gen Virol. 1968 Jul;3(1):97–102. doi: 10.1099/0022-1317-3-1-97. [DOI] [PubMed] [Google Scholar]
  3. Blanden R. V. Mechanisms of recovery from a generalized viral infection: mousepox. I. The effects of anti-thymocyte serum. J Exp Med. 1970 Nov;132(5):1035–1054. doi: 10.1084/jem.132.5.1035. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Blanden R. V. Mechanisms of recovery from a generalized viral infection: mousepox. II. Passive transfer of recovery mechanisms with immune lymphoid cells. J Exp Med. 1971 May 1;133(5):1074–1089. doi: 10.1084/jem.133.5.1074. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cole G. A., Nathanson N. Potentiation of experimental arbovirus encephalitis by immunosuppressive doses of cyclophosphamide. Nature. 1968 Oct 26;220(5165):399–401. doi: 10.1038/220399a0. [DOI] [PubMed] [Google Scholar]
  6. FRIEDMAN R. M., BARONS, BUCKLER C. E., STEINMULLER R. I. The role of antibody, delayed hypersensitivity, and interferon production in recovery of guinea pigs from primary infection with vaccinia virus. J Exp Med. 1962 Sep 1;116:347–356. doi: 10.1084/jem.116.3.347. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Fred S. S., Smith W. W. Radiation sensitivity and proliferative recovery of hemopoietic stem cells in weanling as compared to adult mice. Radiat Res. 1967 Oct;32(2):314–326. [PubMed] [Google Scholar]
  8. Gabrielsen A. E., Good R. A. Chemical suppression of adaptive immunity. Adv Immunol. 1967;6:91–229. doi: 10.1016/s0065-2776(08)60522-2. [DOI] [PubMed] [Google Scholar]
  9. Hirsch M. S., Murphy F. A., Russe H. P., Hicklin M. D. Effects of anti-thymocyte serum on lymphocytic choriomeningitis (LCM) virus infection in mice. Proc Soc Exp Biol Med. 1967 Jul;125(3):980–983. doi: 10.3181/00379727-125-32254. [DOI] [PubMed] [Google Scholar]
  10. Hirsch M. S., Nahmias A. J., Murphy F. A., Kramer J. H. Cellular immunity in vaccinia infection of mice. Anti-thymocyte serum effects on primary and secondary responsiveness. J Exp Med. 1968 Jul 1;128(1):121–132. doi: 10.1084/jem.128.1.121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. LIU O. C., CARTER J. E., DESANCTIS A. N., GEATING J. A., HAMPIL B. A study of the effect of antiserum on poliovirus infection induced by the intraspinal inoculation of rhesus monkeys. J Immunol. 1958 Feb;80(2):106–113. [PubMed] [Google Scholar]
  12. Mackaness G. B., Blanden R. V. Cellular immunity. Prog Allergy. 1967;11:89–140. [PubMed] [Google Scholar]
  13. Miller J. F., Osoba D. Current concepts of the immunological function of the thymus. Physiol Rev. 1967 Jul;47(3):437–520. doi: 10.1152/physrev.1967.47.3.437. [DOI] [PubMed] [Google Scholar]
  14. Mori R., Tasaki T., Kimura G., Takeya K. Depression of acquired resistance against herpes simplex virus infection in neonatally thymectomized mice. Arch Gesamte Virusforsch. 1967;21(3):459–462. doi: 10.1007/BF01241745. [DOI] [PubMed] [Google Scholar]
  15. Murphy B. R., Glasgow L. A. Factors modifying host resistance to viral infection. 3. Effect of whole body x-irradiation on experimental encephalomyocarditis virus infection in mice. J Exp Med. 1968 May 1;127(5):1035–1052. doi: 10.1084/jem.127.5.1035. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Nahmias A. J., Hirsch M. S., Kramer J. H., Murphy F. A. Effect of antithymocyte serum on herpesvirus hominis (type 1) infection in adult mice. Proc Soc Exp Biol Med. 1969 Nov;132(2):696–698. doi: 10.3181/00379727-132-34290. [DOI] [PubMed] [Google Scholar]
  17. Nathanson N., Cole G. A. Immunosuppression and experimental virus infection of the nervous system. Adv Virus Res. 1970;16:397–448. doi: 10.1016/S0065-3527(08)60028-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. ROWE W. P., BLACK P. H., LEVEY R. H. PROTECTIVE EFFECT OF NEONATAL THYMECTOMY ON MOUSE LCM INFECTION. Proc Soc Exp Biol Med. 1963 Oct;114:248–251. doi: 10.3181/00379727-114-28643. [DOI] [PubMed] [Google Scholar]
  19. Robinson T. W., Cureton R. J., Heath R. B. The effect of cyclophosphamide on Sendai virus infection of mice. J Med Microbiol. 1969 May;2(2):137–145. doi: 10.1099/00222615-2-2-137. [DOI] [PubMed] [Google Scholar]
  20. Scheinman J. I., Stamler F. W. Cyclophosphamide and fatal varicella. J Pediatr. 1969 Jan;74(1):117–119. doi: 10.1016/s0022-3476(69)80018-1. [DOI] [PubMed] [Google Scholar]
  21. Sell S. Antilymphocytic antibody: effects in experimental animals and problems in human use. Ann Intern Med. 1969 Jul;71(1):177–196. doi: 10.7326/0003-4819-71-1-177. [DOI] [PubMed] [Google Scholar]
  22. Silverstein S. Macrophages and viral immunity. Semin Hematol. 1970 Apr;7(2):185–214. [PubMed] [Google Scholar]
  23. Starzl T. E., Halgrimson C. G., Penn I., Martineau G., Schroter G., Amemiya H., Putnam C. W., Groth C. G. Cyclophosphamide and human organ transplantation. Lancet. 1971 Jul 10;2(7715):70–74. doi: 10.1016/s0140-6736(71)92046-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Svehag S. E. Formation and dissociation of virus-antibody complexes with special reference to the neutralization process. Prog Med Virol. 1968;10:1–63. [PubMed] [Google Scholar]
  25. Thind I. S., Price W. H. The effect of cyclophosphamide treatment on experimental arbovirus infections. Am J Epidemiol. 1969 Jul;90(1):62–68. doi: 10.1093/oxfordjournals.aje.a121050. [DOI] [PubMed] [Google Scholar]
  26. Tripathy S. P., Mackaness G. B. The effect of cytotoxic agents on the primary immune response to Listeria monocytogenes. J Exp Med. 1969 Jul 1;130(1):1–16. doi: 10.1084/jem.130.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Valentine F. T., Lawrence H. S. Cell-mediated immunity. Adv Intern Med. 1971;17:51–93. [PubMed] [Google Scholar]
  28. Weiner L. P., Cole G. A., Nathanson N. Virus-specific immunologic depression in mice following combined immunization and cyclophosphamide-induced immunosuppression. J Immunol. 1971 Feb;106(2):427–430. [PubMed] [Google Scholar]
  29. Wenner H. A., Cho C. T., Bolano C., Kamitsuka P. S. Monkey pox. IV. Modification of disease pattern by antilymphocytic sera. J Infect Dis. 1969 Sep;120(3):318–331. doi: 10.1093/infdis/120.3.318. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES